← All stocks

Schrodinger, Inc.

SDGR Scheduled selling only
CIK 0001490978 #2259 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$927.97K
$0.00 on a plan · $927.97K straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
−$927.97K
$0.00 against sales at will

By person

19 insiders · 2 transactions
16.6×

Ramy Farid holds 16.6 times base salary in stock. $12.16M of shares against $730.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ramy Farid last reported holding, valued at $30.00, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Akinsanya Karen
See Remarks
$927.97K (2) scheduled
−$927.97K
69,956
0.094%
$2.10M
Friesner Richard
Director
1,369,738
1.8%
$41.09M
+14.6%
Farid Ramy
President & CEO
405,351
0.543%
$12.16M
+119.8%
Lorton Kenneth Patrick
EVP, CTO & COO, Software
89,241
0.119%
$2.68M
+112.2%
Abel Robert Lorne
See Remarks
55,897
0.075%
$1.68M
+498.5%
Tran Yvonne
EVP, CLO & CPO
52,683
0.071%
$1.58M
+340.4%
Jain Rachit
EVP & CFO
50,877
0.068%
$1.53M
+83.5%
Herman Jenny
CAO
34,804
0.047%
$1.04M
+82.5%
Aklian Mannix Vartan
See Remarks
31,193
0.042%
$935.79K
Porges Geoffrey Craig
EVP & CFO
27,544
0.037%
$826.32K
+384.5%
Lynton Michael
Director
25,388
0.034%
$761.64K
+125.7%
Thornberry Nancy
Director
25,388
0.034%
$761.64K
+125.7%
Chodakewitz Jeffrey
Director
25,388
0.034%
$761.64K
+125.7%
OBEROI ARUN
Director
25,388
0.034%
$761.64K
+125.7%
Sender Gary
Director
25,388
0.034%
$761.64K
+125.7%
GINSBERG GARY L
Director
25,388
0.034%
$761.64K
+125.7%
Kapeller-Libermann Rosana
Director
25,388
0.034%
$761.64K
+125.7%
Dugan Margaret
Chief Medical Officer
24,574
0.033%
$737.22K
+63.8%
van Kralingen Bridget A
Director
19,640
0.026%
$589.20K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 31,599
History held since 10 Feb 2020